News Announcement

Morepen Laboratories: Outcome of Board Meeting

This is to inform you that the Board of Directors of the Company, in their meeting held on Monday, 4th February, 2019 (Timings: Meeting commenced at 12.00 Noon and concluded at 02:30 p.m.), have inter-alia considered and approved the Standalone and Consolidated Un-audited Financial Results of the Company for the Quarter and nine-months ended 31st December, 2018, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.